Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when MNKD files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsMannKind shareholders approve director slate, executive pay, and auditor at annual meeting
Filed May 22, 2026 · Period ending May 20, 2026 · ~1 min read
Key Changes
-
low
All nine director nominees elected to board until 2027 annual meeting, including CEO Michael Castagna and Chairman James Shannon, maintaining current board composition.
Item 5.07 verify on EDGAR → -
low
Executive compensation approved by shareholders with 89% support (137M for vs 16M against) in non-binding advisory vote, indicating acceptance of management pay practices.
Item 5.07 verify on EDGAR → -
low
Deloitte & Touche ratified as independent auditor for 2026 with 99% approval, continuing existing audit relationship.
Item 5.07 verify on EDGAR →
Summary
MannKind filed a routine post-annual-meeting 8-K disclosing voting results from its May 20, 2026 shareholder meeting. All proposals passed with strong support, including the re-election of the full nine-member board and approval of executive compensation practices. The say-on-pay vote received 89% approval, suggesting shareholders are generally satisfied with how management is compensated relative to company performance.
For retail investors, this filing represents standard corporate housekeeping with no material changes to company operations, strategy, or governance. The strong voting margins indicate no significant shareholder dissent. Watch for the company's Q2 2026 earnings report and any updates on its Afrezza insulin product commercialization as more meaningful catalysts for the stock.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
MannKind held its 2026 Annual Meeting on May 20, 2026, electing nine directors, approving executive compensation, and ratifying Deloitte as auditor.
Show 2 minor / wording changes
Added in current filing · verify on EDGAR →
Our stockholders elected each of the nine individuals nominated by our Board of Directors to serve as directors until the next annual meeting of stockholders.
All nine director nominees were elected at the Annual Meeting held May 20, 2026. The nominees include James S. Shannon, Michael E. Castagna, Steven B. Binder, Ronald J. Consiglio, Michael A. Friedman, Jennifer Grancio, Anthony Hooper, Sabrina Kay, and Christine Mundkur. Each received majority support from voting shareholders.
Added in current filing · verify on EDGAR →
Our stockholders ratified the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
Shareholders ratified Deloitte & Touche LLP as the independent auditor for fiscal year 2026 with overwhelming support (221,079,329 votes for). This routine vote confirms continuity in the company's external audit relationship.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · May 25, 2026 · How we verify